{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:59:33Z","timestamp":1787317173134,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.heliyon.2023.e14063","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T09:07:36Z","timestamp":1677229656000},"page":"e14063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intensive insulin therapy in sepsis patients: Better data enables better intervention"],"prefix":"10.1016","volume":"9","author":[{"given":"Ling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-cheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2023.e14063_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e14063_bib2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e14063_bib3","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/01.CCM.0000277043.85378.C1","article-title":"National estimates of severe sepsis in United States emergency departments","volume":"35","author":"Wang","year":"2007","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14063_bib4","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1097\/CCM.0000000000004155","article-title":"The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey","volume":"48","author":"Xie","year":"2020","journal-title":"Crit. Care Med."},{"issue":"33","key":"10.1016\/j.heliyon.2023.e14063_bib5","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.3748\/wjg.15.4132","article-title":"Blood glucose control in patients with severe sepsis and septic shock","volume":"15","author":"Hirasawa","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"19","key":"10.1016\/j.heliyon.2023.e14063_bib6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"Van den Berghe","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14063_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccm.2016.01.010","article-title":"Dysglycemia and glucose control during sepsis","volume":"37","author":"Plummer","year":"2016","journal-title":"Clin. Chest Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e14063_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MAJ.0b013e318176abb4","article-title":"Stress-induced hyperglycemia in patients with severe sepsis: a compromising factor for survival","volume":"336","author":"Leonidou","year":"2008","journal-title":"Am. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14063_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/CCM.0b013e3181c02726","article-title":"Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis","volume":"38","author":"Stegenga","year":"2010","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14063_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc7717","article-title":"The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study","volume":"13","author":"Esper","year":"2009","journal-title":"Crit. Care"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e14063_bib11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/acem.12015","article-title":"Hyperlactatemia affects the association of hyperglycemia with mortality in nondiabetic adults with sepsis","volume":"19","author":"Green","year":"2012","journal-title":"Acad. Emerg. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14063_bib12","first-page":"15","article-title":"Blood glucose levels in neonatal sepsis and probable sepsis and its association with mortality","volume":"22","author":"Ahmad","year":"2012","journal-title":"J. Coll. Physicians Surg Pak"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14063_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc12514","article-title":"Stress hyperglycemia: an essential survival response","volume":"17","author":"Marik","year":"2013","journal-title":"Crit. Care"},{"issue":"9677","key":"10.1016\/j.heliyon.2023.e14063_bib14","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","article-title":"Stress hyperglycaemia","volume":"373","author":"Dungan","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e14063_bib15","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00003246-198911000-00021","article-title":"Catecholamines: study of interspecies variation","volume":"17","author":"Hart","year":"1989","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14063_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.TA.0000135158.42242.B1","article-title":"The impact of hyperglycemia on patients with severe brain injury","volume":"58","author":"Jeremitsky","year":"2005","journal-title":"J. Trauma"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14063_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.annfar.2005.10.005","article-title":"[Septic shock: blood glucose regulation]","volume":"25","author":"Orban","year":"2006","journal-title":"Ann. Fr. Anesth. Reanim."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14063_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjms.2022.01.003","article-title":"Use of oral anti-diabetic drugs and risk of hospital and intensive care unit admissions for infections","volume":"364","author":"Rim","year":"2022","journal-title":"Am. J. Med. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e14063_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00592-020-01539-z","article-title":"Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19","volume":"57","author":"Solerte","year":"2020","journal-title":"Acta Diabetol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14063_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/dc18-1760","article-title":"A randomized controlled trial on the safety and efficacy of exenatide therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes","volume":"42","author":"Fayfman","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14063_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdi.13093","article-title":"Dulaglutide-combined basal plus correction insulin therapy contributes to ideal glycemic control in non-critical hospitalized patients","volume":"11","author":"Fushimi","year":"2020","journal-title":"J Diabetes Investig"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e14063_bib22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e14063_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","article-title":"Intensive insulin therapy in the medical ICU","volume":"354","author":"Van den Berghe","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14063_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"Intensive insulin therapy and pentastarch resuscitation in severe sepsis","volume":"358","author":"Brunkhorst","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14063_bib25","first-page":"29","article-title":"Influence and mechanism of a tight control of blood glucose by intensive insulin therapy on human sepsis","volume":"43","author":"Yu","year":"2005","journal-title":"Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14063_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/CCM.0b013e31819542da","article-title":"Tight glycemic control may favor fibrinolysis in patients with sepsis","volume":"37","author":"Savioli","year":"2009","journal-title":"Crit. Care Med."},{"issue":"13","key":"10.1016\/j.heliyon.2023.e14063_bib27","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e14063_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1016\/j.heliyon.2023.e14063_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4158\/EP.10.S2.17","article-title":"Role of intravenous insulin therapy in critically ill patients","volume":"10","author":"Van den Berghe","year":"2004","journal-title":"Endocr. Pract."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14063_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/SHK.0000000000000778","article-title":"Diabetes mellitus and sepsis: a challenging association","volume":"47","author":"Trevelin","year":"2017","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14063_bib31","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/jc.2002-021478","article-title":"Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels","volume":"88","author":"Hansen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e14063_bib32","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes\u20142013","volume":"36","author":"Association","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e14063_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy","volume":"342","author":"Lachin","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14063_bib34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2337\/diacare.29.02.06.dc05-1549","article-title":"Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion","volume":"29","author":"Martin","year":"2006","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14063_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e14063_bib36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jama.300.8.933","article-title":"Benefits and risks of tight glucose control in critically ill adults: a meta-analysis","volume":"300","author":"Wiener","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2023.e14063_bib37","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00134-004-2210-z","article-title":"Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock","volume":"30","author":"Dellinger","year":"2004","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.heliyon.2023.e14063_bib38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00134-006-0100-2","article-title":"Hypoglycaemia? So what","volume":"32","author":"Mackenzie","year":"2006","journal-title":"Intensive Care Med."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e14063_bib39","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1097\/01.CCM.0000242913.88721.6E","article-title":"First do no harm hypoglycemia or hyperglycemia","volume":"34","author":"Van den Berghe","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.heliyon.2023.e14063_bib40","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1164\/ajrccm.164.10.2103068","article-title":"Practical management of diabetes in critically ill patients","volume":"164","author":"Boord","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14063_bib41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/CCM.0b013e318194b097","article-title":"Early blood glucose control and mortality in critically ill patients in Australia","volume":"37","author":"Bagshaw","year":"2009","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14063_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229919","article-title":"Impact of blood glucose abnormalities on outcomes and disease severity in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis","volume":"15","author":"Kushimoto","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14063_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc6837","article-title":"Pro\/con debate: is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients","volume":"12","author":"Merz","year":"2008","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14063_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.CCM.0000194536.89694.06","article-title":"Predisposing factors for hypoglycemia in the intensive care unit","volume":"34","author":"Vriesendorp","year":"2006","journal-title":"Crit. Care Med."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e14063_bib45","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.2337\/db06-0855","article-title":"Intensive insulin therapy in mixed medical\/surgical intensive care units: benefit versus harm","volume":"55","author":"Van den Berghe","year":"2006","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e14063_bib46","first-page":"392","article-title":"Indication and practical use of intensive insulin therapy in the critically ill","volume":"13","author":"Mebis","year":"2007","journal-title":"Curr. Opin. Crit. Care"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e14063_bib47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdi.12209","article-title":"Clinical characteristics of hyperglycemic crises in patients without a history of diabetes","volume":"5","author":"Chou","year":"2014","journal-title":"J. Diabetes Investig"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e14063_bib48","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/0885066619833910","article-title":"Characteristics and outcomes of patients with and without type 2 diabetes mellitus and pulmonary sepsis","volume":"35","author":"Sathananthan","year":"2020","journal-title":"J. Intensive Care Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14063_bib49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/0148607194018003214","article-title":"Anabolic effects of insulin and amino acids in promoting nitrogen accretion in postoperative patients","volume":"18","author":"Valarini","year":"1994","journal-title":"JPEN - J. Parenter. Enter. Nutr."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e14063_bib50","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","article-title":"Increased mortality associated with growth hormone treatment in critically ill adults","volume":"341","author":"Takala","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.heliyon.2023.e14063_bib51","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJM200205163462016","article-title":"Intensive insulin therapy in critically ill patients","volume":"346","author":"Hirsch","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14063_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fasebj.8.1.8299889","article-title":"Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures","volume":"8","author":"Klip","year":"1994","journal-title":"Faseb. J."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e14063_bib53","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199908263410907","article-title":"Treatment of diabetic retinopathy","volume":"341","author":"Ferris","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e14063_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046582","article-title":"Increasing blood glucose variability is a precursor of sepsis and mortality in burned patients","volume":"7","author":"Pisarchik","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14063_bib55","first-page":"489","article-title":"Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function","volume":"70","author":"Mayfield","year":"2004","journal-title":"Am. Fam. Physician"},{"issue":"Suppl 2","key":"10.1016\/j.heliyon.2023.e14063_bib56","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2337\/dc08-s235","article-title":"Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes","volume":"31","author":"Pickup","year":"2008","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14063_bib57","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1464-5491.2006.01811.x","article-title":"Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion","volume":"23","author":"Moyes","year":"2006","journal-title":"Diabet. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e14063_bib58","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s13300-020-00855-5","article-title":"Rationale for timely insulin therapy in type 2 diabetes within the framework of individualised treatment: 2020 update","volume":"11","author":"Hanefeld","year":"2020","journal-title":"Diabetes Ther"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14063_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.diabet.2009.09.002","article-title":"When to treat a diabetic patient using an external insulin pump. Expert consensus. Soci\u00e9t\u00e9 francophone du diab\u00e8te (ex ALFEDIAM) 2009","volume":"36","author":"Lassmann-Vague","year":"2010","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.heliyon.2023.e14063_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.heliyon.2023.e14063_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock","volume":"34","author":"Dellinger","year":"2008","journal-title":"Intensive Care Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14063_bib62","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e14063_bib63","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1097\/CCM.0b013e3181a381ad","article-title":"Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality","volume":"37","author":"Arabi","year":"2009","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e14063_bib64","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s00134-004-2252-2","article-title":"Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults","volume":"30","author":"Kanji","year":"2004","journal-title":"Intensive Care Med."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e14063_bib65","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJM197412122912404","article-title":"Stabilization of plasma glucose during fasting: normal variations in two separate studies","volume":"291","author":"Merimee","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e14063_bib66","first-page":"237","article-title":"Thesurgical therapy of hyperinsu-linism","volume":"3","author":"Whipple","year":"1938","journal-title":"J. Int. Chir"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e14063_bib67","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2337\/diacare.14.11.949","article-title":"Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM: factor-analysis approach","volume":"14","author":"Hepburn","year":"1991","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e14063_bib68","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2337\/diab.42.12.1791","article-title":"Mechanism of awareness of hypoglycemia: perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms","volume":"42","author":"Towler","year":"1993","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e14063_bib69","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ecl.2006.09.005","article-title":"Hypoglycemia","volume":"35","author":"Guettier","year":"2006","journal-title":"Endocrinol Metab. Clin. N. Am."},{"issue":"16","key":"10.1016\/j.heliyon.2023.e14063_bib70","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14063_bib71","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/SHK.0000000000000778","article-title":"Diabetes mellitus and sepsis: a challenging association","volume":"47","author":"Trevelin","year":"2017","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14063_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-016-1429-8","article-title":"Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients","volume":"20","author":"van Vught","year":"2016","journal-title":"Crit. Care"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e14063_bib73","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/0885066619833910","article-title":"Characteristics and outcomes of patients with and without type 2 diabetes mellitus and pulmonary Sepsis","volume":"35","author":"Sathananthan","year":"2020","journal-title":"J. Intensive Care Med."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e14063_bib74","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/dia.2012.0008","article-title":"Real-time continuous glucose monitoring in an intensive care unit: better accuracy in patients with septic shock","volume":"14","author":"Lorencio","year":"2012","journal-title":"Diabetes Technol. Therapeut."},{"issue":"9453","key":"10.1016\/j.heliyon.2023.e14063_bib75","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials:\u201cto whom do the results of this trial apply?\u201d","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"issue":"9 Suppl","key":"10.1016\/j.heliyon.2023.e14063_bib76","doi-asserted-by":"crossref","first-page":"S503","DOI":"10.1097\/01.CCM.0000278046.24345.C7","article-title":"Clinical experience with tight glucose control by intensive insulin therapy","volume":"35","author":"Preiser","year":"2007","journal-title":"Crit. Care Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023012707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023012707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:54:36Z","timestamp":1776214476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023012707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2405844023012707"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14063","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensive insulin therapy in sepsis patients: Better data enables better intervention","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e14063"}}